Cohance Lifesciences Limited
COHANCE
Rangering i aksjer
#6371
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aksjekurs
$5.05
Sist synkronisert: 2026-10-19
Markedsverdi
$1.93B
Endring (1 dag)
-1.44%
Endring (1 år)
-57.38%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Utbyttehistorikk for Cohance Lifesciences Limited (COHANCE)
Cohance Lifesciences Limited (aksjesymbol: COHANCE) har gitt totalt 5 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $10.00
Utbytteavkastning (TTM): 0
Summen av alle utbytter (justert for aksjesplitt): $10.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Cohance Lifesciences Limited (COHANCE) fra 2021 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $5.00 | -37.50% |
| 2022 | $8.00 | 300.00% |
| 2021 | $2.00 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $5.00 | -37.50% |
| 2022 | $8.00 | 300.00% |
| 2021 | $2.00 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
